Capstan Therapeutics
Global biopharmaceutical company conducting integrated discovery, development, clinical testing and manufacturing of therapeutics across biologics, small molecules, gene therapies, ophthalmology, neuroscience and aesthetic medicine. Maintains a large marketed product portfolio, global regulatory and pharmacovigilance systems, contract manufacturing capabilities and partnership programs to source external innovation.
Industries
Nr. of Employees
medium (51-250)
Capstan Therapeutics
Patents
Products
R&D pipeline across biologics, small molecules, gene therapy and devices
Portfolio of compounds, devices and indications in development spanning biologics (including multispecific formats and conjugates), small molecules, gene therapies, injectable biomaterials and medical devices across oncology, immunology, neuroscience, ophthalmology and aesthetics.
R&D pipeline across biologics, small molecules, gene therapy and devices
Portfolio of compounds, devices and indications in development spanning biologics (including multispecific formats and conjugates), small molecules, gene therapies, injectable biomaterials and medical devices across oncology, immunology, neuroscience, ophthalmology and aesthetics.
Services
End-to-end manufacturing services from development through commercialization offering GMP supply and supply‑chain support.
Sourcing, evaluating and managing collaborations across discovery, development and commercialization, including strategic investment via venture arm.
Programs to support patient access, affordability and education including patient assistance and co-pay programs.
Technical and submission support for investigator-initiated clinical studies through a dedicated submission portal.
End-to-end manufacturing services from development through commercialization offering GMP supply and supply‑chain support.
Sourcing, evaluating and managing collaborations across discovery, development and commercialization, including strategic investment via venture arm.
Programs to support patient access, affordability and education including patient assistance and co-pay programs.
Technical and submission support for investigator-initiated clinical studies through a dedicated submission portal.
Expertise Areas
- Clinical trial management
- Biotherapeutic discovery and development
- Small‑molecule drug discovery
- Gene therapy and in vivo delivery
Key Technologies
- Monoclonal and multispecific antibody engineering
- Antibody–drug conjugate platforms
- Small‑molecule medicinal chemistry
- Peptide therapeutics
News & Updates
Completion of acquisition of a therapeutics company announced as an addition to AbbVie's R&D capabilities.
Completion of acquisition of a therapeutics company announced as an addition to AbbVie's R&D capabilities.